Chesapeake Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-57
Closed -$3.16K – 511
2025
Q1
$3.16K Sell
57
-34
-37% -$1.84K ﹤0.01% 297
2024
Q4
$4.39K Hold
91
– – ﹤0.01% 264
2024
Q3
$5.24K Hold
91
– – ﹤0.01% 252
2024
Q2
$4.42K Hold
91
– – ﹤0.01% 251
2024
Q1
$4.42K Hold
91
– – ﹤0.01% 247
2023
Q4
$4.53K Sell
91
-240
-73% -$11.7K ﹤0.01% 308
2023
Q3
$17.8K Buy
331
+91
+38% +$4.85K 0.02% 206
2023
Q2
$12.9K Hold
240
– – 0.01% 234
2023
Q1
$13.1K Buy
+240
New +$11.7K 0.01% 223

Other funds holding SNY

Chesapeake Asset Management's SNY Position: Q2 2025 in Review

Chesapeake Asset Management sold out of Sanofi (SNY) in Q2 2025, closing a stake of 57 shares — an estimated $3.16K sold.

Chesapeake Asset Management first reported a position in SNY in Q1 2023 and held it in 9 quarters. The position peaked at $17.8K in Q3 2023. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Chesapeake Asset Management reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 57 Sanofi shares in Q2 2025, an estimated $3.16K.
  • Chesapeake Asset Management first reported a position in Sanofi in Q1 2023 and held it in 9 quarters.
  • Chesapeake Asset Management's Sanofi position peaked at $17.8K in Q3 2023.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Chesapeake Asset Management's 13F filing for Q2 2025, filed 15 Oct 2025.